Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer

Niclosamide, an anthelmintic drug approved by the US Food and Drug Administration against cestodes, is used to treat tapeworm infection. In this study, we show that niclosamide can potentially inhibit signal transducer and activator of transcription 3 (STAT3) in colon cancer cell lines. Combined inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Lingyi, Zheng, Hailun, Hu, Wanle, Zhou, Bin, Dai, Xuanxuan, Zhang, Yi, Liu, Zhiguo, Wu, Xiaoping, Zhao, Chengguang, Liang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370071/
https://www.ncbi.nlm.nih.gov/pubmed/28367059
http://dx.doi.org/10.2147/OTT.S129449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370071/
https://www.ncbi.nlm.nih.gov/pubmed/28367059
http://dx.doi.org/10.2147/OTT.S129449

Ejemplares similares